← Back to Dashboard

MANKIND Mankind Pharma Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare
₹ 2,384.00
-0.04%
1-year price · range ₹1,927–₹2,638

Live setups screens MANKIND is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Long Unwinding
Longs are exiting (OI down -1.5%) as price declines (-0.5%), indicating lack of holding support.

Analysis what the data is telling us about MANKIND

In the last completed session, Mankind Pharma Ltd. closed -0.47% with futures open interest moving -1.5%. That combination — price falling while OI shrinks — is classified as Long Unwinding. Existing longs are exiting rather than new shorts being added; the move down lacks the conviction of fresh selling. The stock's option PCR sits at 0.59, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹2,440 sits 2.3% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Mankind Pharma Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Mankind Pharma Ltd. leans cautious into the next session.

F&O Positioning EOD derivatives setup

Buildup Class
Long Unwinding
bias: bearish
Futures OI
3,243,500
-49000 (-1.5%)
Option PCR (OI)
0.59
heavy call writing
Max Pain Strike
₹ 2,440
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 2,385.00
yesterday's EOD close
Index Contribution
not a Nifty 50 constituent
Traded Volume
343,261
live shares traded today
Upcoming Earnings
no report scheduled

Technical Snapshot from 400 sessions of price history

RSI (14)
39.8
neutral momentum
52-Week High
₹ 2,674.00
-10.8% from high
52-Week Low
₹ 1,909.70
+24.9% above low
200-DMA
₹ 2,276.47
+4.8% · above trend
50-DMA
₹ 2,480.07
-3.8% from 50-DMA
1-Year Return
-3.5%
1M -6.3%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
48.3
price / earnings
P/B
6.0
price / book
ROE
return on equity
Market Cap
₹ 98,343 Cr
total market value
Dividend Yield
0.08%
trailing yield
EPS (TTM)
₹ 49.32
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Broker Calls as reported · last 120 days

DateBrokerageCallTargetSource
2026-08-20 InCred Initiate NDTV Profit
2026-08-19 InCred Initiate NDTV Profit
2026-08-18 InCred Initiate NDTV Profit
2026-08-17 InCred Initiate NDTV Profit
2026-08-02 InCred Initiate NDTV Profit
2026-08-01 InCred Initiate NDTV Profit
2026-07-30 InCred Initiate NDTV Profit
2026-07-29 InCred Initiate NDTV Profit
2026-07-28 InCred Initiate NDTV Profit
2026-07-27 InCred Initiate NDTV Profit
2026-07-26 InCred Initiate NDTV Profit
2026-07-25 InCred Initiate NDTV Profit
Analyst calls as reported in the business press — collected and matched by Strota, not recommendations. Targets are the reporting publication's figures.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-08-25 · spot 2,384 · EOD 2026-08-21

Option writers expect range between 2,300 and 2,800+17.5% upside, -3.5% downside.
upside-skewed
Call OI (writers) Strike Put OI (writers)
0
IV 277% Δ 0.63 θ -32.8 ν 1
2260
750 +0k
0
IV 211% Δ 0.62 θ -25.2 ν 1
2280
47,000 -8k
16,000 -4k
2300 S
254,250 -177k
750 +0k
2320
28,250 -5k
IV 23% Δ -0.12 θ -1.4 ν 1
2,500
IV 36% Δ 0.70 θ -4.2 ν 1
2340
20,750 -9k
IV 22% Δ -0.19 θ -1.8 ν 1
18,000 +5k
IV 15% Δ 0.75 θ -1.8 ν 1
2360
29,000 +1k
IV 22% Δ -0.31 θ -2.2 ν 1
31,500 +3k
IV 13% Δ 0.57 θ -1.9 ν 1
2380
129,500 -8k
IV 20% Δ -0.45 θ -2.2 ν 1
113,000 -33k
IV 16% Δ 0.36 θ -2.1 ν 1
2400
59,250 -13k
IV 21% Δ -0.60 θ -2.3 ν 1
143,750 +36k
IV 18% Δ 0.23 θ -1.8 ν 1
2420
31,000 -4k
IV 20% Δ -0.75 θ -1.7 ν 1
99,500 -26k
IV 19% Δ 0.13 θ -1.3 ν 1
2440 MP
23,000 -3k
IV 29% Δ -0.77 θ -2.4 ν 1
144,500 -18k
2460
39,500
37,250 -1k
2480
38,000 +0k
IV 32% Δ -0.87 θ -1.7 ν 1
186,750 -64k
2500
41,500 -9k
IV 32% Δ -0.92 θ -1.1 ν 0

Chain Interpretation

Spot Underlying 2,383.78
Key Resistance (R) 2,800
Key Support (S) 2,300
Max Pain Strike (MP) 2,440
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for MANKIND options · 2026-08-25 expiry

Underlying: MANKIND · Spot: ₹ 2,383.78 · Expiry: 2026-08-25 · Lot: 250

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

MANKIND — frequently asked questions

What is the Mankind Pharma Ltd. share price today?

MANKIND is trading at ₹2,384.00 (-0.04% vs previous close), per the latest update on this page.

What is the P/E ratio of Mankind Pharma Ltd.?

MANKIND (Mankind Pharma Ltd.) has a trailing twelve-month P/E ratio of 48.3.

What is the market cap of Mankind Pharma Ltd.?

MANKIND has a market capitalisation of approximately ₹98,343 crore.

Is MANKIND near its 52-week high?

MANKIND is trading -10.8% from its 52-week high of ₹2,674.00 as of 2026-08-20.

What is the RSI of MANKIND?

The 14-day RSI of MANKIND is 39.8, which is considered neutral.

Is MANKIND above its 200-day moving average?

MANKIND is trading above its 200-DMA of ₹2,276.47 (+4.8% away).

What is the F&O buildup in MANKIND?

The latest end-of-day derivatives data classifies MANKIND as Long Unwinding (bias: bearish), based on the day's combined price and open-interest change.

What is the max pain and PCR for MANKIND options?

MANKIND's option-chain max pain strike is ₹2,440 and its put-call ratio (OI) is 0.59, from the latest end-of-day option chain.

Are FIIs or big investors buying MANKIND?

Strota tracks every bulk and block deal in MANKIND with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.

What is the latest broker call on MANKIND?

The most recent analyst call reported in the press is InCred: Initiate (2026-08-20). The Broker Calls section on this page lists reported calls from the last 120 days with links to the original reports.